Routine treatment of rheumatoid arthritis with biologics and targeted agents: changes in patients and their response over 15 years
Ann Rheum Dis
.
2022 Jun 14:annrheumdis-2022-222207.
doi: 10.1136/annrheumdis-2022-222207.
Online ahead of print.
Authors
Ingrid M Visman
1
,
Maarten Boers
2
,
Daisy Vedder
3
,
Jos Wr Twisk
2
,
Michael T Nurmohamed
3
4
Affiliations
1
Reade, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands i.visman@reade.nl.
2
Epidemiology & Data Science, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.
3
Reade, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.
4
Amsterdam UMC, Vrije Universiteit, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.
PMID:
35701151
DOI:
10.1136/annrheumdis-2022-222207
No abstract available
Keywords:
Biological Therapy; Rheumatoid Arthritis; Tumor Necrosis Factor Inhibitors.